slide1 n.
Skip this Video
Loading SlideShow in 5 Seconds..
Clinical Trials Submitted Successfully – Session #12 Heritage Gallery Presenters: PowerPoint Presentation
Download Presentation
Clinical Trials Submitted Successfully – Session #12 Heritage Gallery Presenters:

Loading in 2 Seconds...

play fullscreen
1 / 40

Clinical Trials Submitted Successfully – Session #12 Heritage Gallery Presenters: - PowerPoint PPT Presentation

  • Uploaded on

Clinical Trials Submitted Successfully – Session #12 Heritage Gallery Presenters: Laura Williams – Sponsored Projects Administration Debra Dykhuis – Office of Clinical Research Bridget Foss – Sponsored Projects Administration. Clinical Trials Trivia Time.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'Clinical Trials Submitted Successfully – Session #12 Heritage Gallery Presenters:' - alijah

Download Now An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

Clinical Trials Submitted Successfully – Session #12

Heritage Gallery


Laura Williams – Sponsored Projects Administration

Debra Dykhuis – Office of Clinical Research

Bridget Foss – Sponsored Projects Administration


Clinical Trials Trivia Time

  • According to, there are approximately

how many open clinical studies underway

in the state of Minnesota?


order of presentation
Order of Presentation

Laura Williams – Feasibility Considerations

in Clinical Trials

Debra Dykhuis – Budgetary Considerations

in Clinical Trials

Bridget Foss - SPA Submission Processes and Shortcuts

what we ll cover today
Protocol Review Considerations

Ethical Considerations

Business Considerations

Scientific Review

Institutional Review

Regents Policies

Certainly not to be ignored, but not covered today:




Investigator-sponsored clinical trials

What We’ll Cover Today
  • Population
  • Staff
  • Space
  • Technical capability
  • Cost per subject
  • Complexity of protocol
  • Duration of study
  • Survivability
scientific merit
Scientific Merit
  • Adequate study design
  • Main hypothesis
  • Blinding, randomization
  • Biostatistical methodology
  • Endpoints
  • Publishability
ethical considerations
Ethical Considerations
  • Target population
  • Safety
  • Severity of disease
  • Availability of alternative treatments
  • Side effects
  • Peds / Elderly
  • Underserved populations
business considerations
Business Considerations
  • Frequency and complexity of monitoring visits
  • Closeout visits
  • Funder resources and assistance during the trial
  • Working with the PI
  • Cost sharing
  • Multi-departmental
business considerations1
Business Considerations
  • CRO involvement
  • Past dealings with sponsor
  • History of timely payments (or not!)
  • SIV Process
business considerations the clinical trial agreement
Business Considerations – The Clinical Trial Agreement
  • Publications
    • University’s policies and continuing tax status are dependent on fulfilling our threefold mission:
      • Research and Discovery
      • Teaching and Learning
      • Outreach and Public Service
  • Intellectual Property
    • Terms must also be respondent to the University research mission
    • Principles of exercising academic freedom
  • Indemnification and Subject Injury
  • Payments
    • Important to understand these are negotiable
    • SPA will defer to the coordinator/PI
scientific review
Scientific Review
  • To be performed by independent, peer reviewers – no one from the research team
  • One of three methods must be utilized
    • Full peer review by grant committee of NIH, NSF or a foundation – excludes industry sponsored clinical trials; or
    • U of M scientific review committees; or
    • CPRC provides initial evaluation and review of all University of Minnesota clinical cancer research protocols, and monitors and renews the protocols annually. Those with low success may be terminated.
scientific review1
Scientific Review
  • General Clinical Research Center (GCRC) Scientific Advisory Committee – only if GCRC center is utilized
  • Protocol Review and Data Use (PRDU) - protocols involving solid organ transplant
  • Interdisciplinary Site Specific Committee – translational
  • Others – Surgery, OB/Gyn
  • Any appropriately constituted departmental or collegiate – at least two reviewers reach consensus on science, documentation of the review process filed with the college-level associate dean
  • Required prior to IRB submission
regents policies
Regents Policies
  • Openness in Research - Subd. 1
    • The University shall not accept support from any source for research under a contract or grant that prohibits the disclosure of the research relationship, the nature of the research…..
  • IP Sharing
    • Commercialization activities are encouraged per Policy
    • Can not inhibit open research
    • Research should result in generation and dissemination of new knowledge
  • Ethics
    • Just the appearance of impropriety is to be avoided
institutional research review and committees
Institutional Research Review and Committees
  • IRB – Human subjects
  • COI – Financial or other types of potential conflicts of interest
  • ICD
  • IBC - recombinant DNA, infectious agents or biologically derived toxins
  • AURPAC - ionizing radiation
reference resource
Reference Resource


Laura Williams, Principal Grant and Contract Administrator

clinical trials submitted successfully

Clinical Trials Submitted Successfully

Estimating Personnel Time and Optimizing Payment Terns

Debra Dykhuis


the crystal ball approach to estimating personnel time
The crystal ball approach to estimating personnel time……
  • “…there are many ways of losing money. Women are the most fun. Gambling is the fastest. Research is the most certain.”

Lord Hives,

Former Chairman of Rolls Royce

what is at stake
What is at stake?
  • Quality of the data
  • Speed of accrual
  • Attention to compliance
  • Prospects of getting future research funding
  • Staff burnout/turnover
  • Jobs
what can be done
What can be done?
  • Have a clear clinical trial plan
  • Abandon the notion that guessing is the best we can do
  • Abandon the notion that the sponsor, agency, or center knows what it will cost to do the trial (and has our best interests at heart)
  • Create a column for every time point data will be collected
  • Create a row for every person who will have a job to do
what can be done1
What can be done?
  • Consider what each person will be required to do for each visit and write it down
  • Attach an estimate of time to do each part of the work
  • Ask the person who will be doing it what they think of the estimate
  • Adjust as needed and enter the number of hours required for each protocol time point or visit
what can be done2
What can be done?
  • Be sure to consider time staff will spend at research meetings, on subject recruitment, the time to prepare for research subject visits and the follow-up that might be needed, event reporting, managing interactions with monitors, and data queries
  • For industry trials, include time for start-up and close out, regulatory documents, amendment processing, etc.
what do we know
What do we know?
  • Reviewed time data for 20 clinical trials completed 2005-2007
  • Areas of cancer, solid organ transplant, critical care, rare diseases
  • Average time per study visit for a research coordinator – 11 hours
  • Average start-up time – 45 hours for regulatory processes; 24 hours for clinical research coordinator
applying what we know
Applying what we know
  • Approximately 35% of an employee’s appointment time is consumed by vacation/sick leave, breaks, and other work that may not be directly related to a clinical trial
  • Consider this when writing budgets that require budgeting by FTEs
  • Example: a .5 research coordinator on a solid organ transplant study will be able to manage about 61 visits per year (at 11 hrs/visit)
optimizing contract payment terms in agreements with industry
Optimizing contract payment terms in agreements with industry
  • Start date: terms should allow payment for work as soon as it starts
  • End date: should be “until all study work completed”
  • Start-up and close-out costs: should be non-refundable, unrelated to subject enrollment, payable on contract execution
  • Final payment: not more than 10% withheld
  • Payment frequency: no less than quarterly for work performed
  • Items payable on invoice: limit these to items that will truly be sporadic or unpredictable (not as a way of making reimbursement conditional)
  • Good Clinical Practice Protocol Template
  • Clinical Trial Budget Template
clinical trials submitted successfully1

Clinical Trials Submitted Successfully

SPA Processes

Bridget Foss


expedited process for industry funded clinical trials
Expedited Process for Industry Funded Clinical Trials

This process allows SPA to negotiate the

Agreement while the department is completing

budget negotiations.

Expedited PRF Package Includes:

  • Draft PRF signed by Principal Investigator
  • Draft Budget
  • Draft Protocol
  • Agreement (if available)

* It is essential that a sponsor contact is included on the PRF for this process to be effective.

standard final prf package
Standard (“Final”) PRF Package

Proposals, non-industry funded trials, and

industry funded trials after budget

negotiation require the following:

  • Fully Routed PRF
  • Final Protocol
  • Negotiated Budget
  • TASCS Billing Grid
Is the trial investigator sponsored?

Is the project an animal clinical trial or pre-clinical research?

What is the appropriate F&A rate for this particular project?

Industry Funded Clinical Trial: 26% TDC

Non-Industry Funded Clinical Trial: 51% MTDC

Pre-Clinical Research: 51% MTDC

Questions to Consider During PRF Prep

compliance checks
Compliance Checks

Compliance requirements for Investigators:

  • Approved REPA
  • Completed RCR training (or approved extension)

SPA also checks the RSPP database for human subjects, animal subjects and/or IBC approvals. Please note that the title used on the PRF needs to match the protocol title approved by RSPP.

advance account
Advance Account
  • If costs are incurred prior to execution of the agreement, an advance account should be requested.
  • SPA attempts to insert language allowing pre-award costs; however, all pre-award costs are incurred at the department’s risk.
  • Departments often request advance account in order to complete Fairview submissions.
agreement negotiation
Agreement Negotiation
  • SPA reviews and negotiates the contract language for conformity with University policy, and works in consultation with the Office of General Counsel, the Office of Technology Commercialization, and the Principal Investigator.
  • Problem clauses may include publication, confidentiality, intellectual property, and indemnification.

Negotiations take time!

agreement execution
Agreement Execution
  • If expedited process is used, SPA will not execute the agreement until it receives the final PRF package.
  • Compliance issues need to be resolved prior to execution and award set up.
  • Agreements are sent to the investigators for final review and or approval prior to University execution.
award set up for industry funded clinical trials
Award Set Up for Industry Funded Clinical Trials
  • Fixed price industry funded clinical trials are set up in accordance with the University procedure “Handling Industry Sponsored Clinical Trial Research Agreements.”
  • Accounts are initially set up for $0. Dollars are set up on the Project by Sponsored Financial Reporting as funds are received. It is the department’s responsibility to re-budget dollars into the appropriate accounts based on the budget.
award set up for non industry funded clinical trials
Award Set Up for Non-Industry Funded Clinical Trials
  • Cost reimbursable awards and non-industry funded trials are set up based on the department provided and sponsor approved budget for the current period.

Account set up, regardless of funding source, is subject to the terms and conditions of the agreement governing the project. Each project is handled on a case by case basis.

  • B&I Expedited Procedure:
  • F&A Rates:
  • Advance Account Policy:
  • Openness in Research policy:
  • Handling Industry-Sponsored Clinical Trial Research Agreements: